183 related articles for article (PubMed ID: 18619191)
1. Prophylaxis and therapy of central nervous system involvement in adult acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Giebel S; Krawczyk-Kuliś M; Adamczyk-Cioch M; Czyz A; Lech-Marańda E; Piatkowska-Jakubas B; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Jun; 118(6):356-61. PubMed ID: 18619191
[TBL] [Abstract][Full Text] [Related]
2. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
3. Central nervous system involvement in adult acute lymphoblastic leukemia.
Thomas X; Le QH
Hematology; 2008 Oct; 13(5):293-302. PubMed ID: 18854093
[TBL] [Abstract][Full Text] [Related]
4. [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].
Thomas X; Pavan L; Le QH
Bull Cancer; 2008; 95(7):707-15. PubMed ID: 18755650
[TBL] [Abstract][Full Text] [Related]
5. Managing CNS disease in adults with acute lymphoblastic leukemia.
Larson RA
Leuk Lymphoma; 2018 Jan; 59(1):3-13. PubMed ID: 28535095
[TBL] [Abstract][Full Text] [Related]
6. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
[TBL] [Abstract][Full Text] [Related]
7. Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.
Sancho JM; Morgades M; Arranz R; Fernández-Abellán P; Deben G; Alonso N; Blanes M; Rodríguez MJ; Nicolás C; Sánchez E; Fernández de Sevilla A; Conde E; Ribera JM;
Med Clin (Barc); 2008 Oct; 131(11):401-5. PubMed ID: 18928719
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate infusions as central nervous system prophylaxis in children with acute lymphocytic leukemia: the Norwegian experience.
Moe PJ; Holen A; Nygaard R; Glomstein A; Madsen B; Hellebostad M; Stokland T; Wefring KW; Steen-Johnsen J; Nielsen B; Hapnes C; Børsting S
Pediatr Hematol Oncol; 2003; 20(3):187-200. PubMed ID: 12637215
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment.
Pui CH
Hematology Am Soc Hematol Educ Program; 2006; ():142-6. PubMed ID: 17124053
[TBL] [Abstract][Full Text] [Related]
10. Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia.
Mahmoud HH; Rivera GK; Hancock ML; Krance RA; Kun LE; Behm FG; Ribeiro RC; Sandlund JT; Crist WM; Pui CH
N Engl J Med; 1993 Jul; 329(5):314-9. PubMed ID: 8321259
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of prophylactic additional cranial irradiation and intrathecal chemotherapy for the prevention of CNS relapse after allogeneic hematopoietic SCT for childhood ALL.
Fukano R; Nishimura M; Ito N; Nakashima K; Kodama Y; Okamura J; Inagaki J
Pediatr Transplant; 2014 Aug; 18(5):518-23. PubMed ID: 24815062
[TBL] [Abstract][Full Text] [Related]
12. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
13. Controversies in the management of central nervous system leukemia.
Barredo J; Ritchey AK
Pediatr Hematol Oncol; 2010 Aug; 27(5):329-32. PubMed ID: 20469977
[TBL] [Abstract][Full Text] [Related]
14. [Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].
Zając-Spychała O; Wachowiak J
Med Wieku Rozwoj; 2012; 16(2):128-37. PubMed ID: 22971657
[TBL] [Abstract][Full Text] [Related]
15. Tailored central nervous system-directed treatment strategy for isolated CNS recurrence of adult acute myeloid leukemia.
Zheng C; Liu X; Zhu W; Cai X; Wu J; Sun Z
Hematology; 2014 Jun; 19(4):208-12. PubMed ID: 24074528
[TBL] [Abstract][Full Text] [Related]
16. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
17. The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia.
Sanders KE; Ha CS; Cortes-Franco JE; Koller CA; Kantarjian HM; Cox JD
Cancer; 2004 May; 100(10):2176-80. PubMed ID: 15139061
[TBL] [Abstract][Full Text] [Related]
18. Central nervous system prophylaxis in diffuse large B-cell lymphoma.
Zahid MF; Khan N; Hashmi SK; Kizilbash SH; Barta SK
Eur J Haematol; 2016 Aug; 97(2):108-20. PubMed ID: 27096423
[TBL] [Abstract][Full Text] [Related]
19. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study .
Ritchey AK; Pollock BH; Lauer SJ; Andejeski Y; Barredo J; Buchanan GR
J Clin Oncol; 1999 Dec; 17(12):3745-52. PubMed ID: 10577846
[TBL] [Abstract][Full Text] [Related]
20. Central nervous system disease in hematologic malignancies: historical perspective and practical applications.
Pui CH; Thiel E
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S2-S16. PubMed ID: 19660680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]